Variable | OR (95% CI) | p-value |
---|---|---|
VO2 max (continuous) | 0.82 (0.77–0.86) | < 0.001 |
AT (continuous) | 0.66 (0.61–0.71) | < 0.001 |
AT VE/VCO2 (continuous) | 1.33 (1.26–1.40) | < 0.001 |
COPD | ||
 No | 1 | 0.001 |
 Yes | 1.99 (1.33–2.98) |  |
Chronic renal impairment | ||
 No | 1 | < 0.001 |
 Yes | 7.50 (4.29–13.10) |  |
Age group | ||
  > 70 years | 1 | 0.001 |
 51–70 years | 0.35 (0.18–0.69) | 0.003 |
 < 50 years | 0.25 (0.12–0.51) | < 0.001 |
Diabetic status | ||
 Negative | 1 | 0.002 |
 Insulin | 2.54 (1.52–4.23) | < 0.001 |
 Non-insulin dependent | 1.02 (0.98–1.06) | 0.831 |
BMI categories | ||
 < 18.5 | 6.98 (2.91–16.74) | < 0.001 |
 18.5–24.99 | 1 | < 0.001 |
 ≥ 25.0 | 1.72 (0.90–3.30) | 0.102 |
Surgery type | ||
 Robotic/laparoscopic | 1 | < 0.001 |
 Open | 10.80 (5.77–20.19) |  |
Cancer stage | ||
 Primary | 1 | 0.006 |
 Local nodal metastases | 1.61 (0.84–3.09) | 0.153 |
 Distant metastases | 11.22 (2.31–54.66) | 0.003 |
WHO category | ||
 0 | 1 | < 0.001 |
 ≥ 1 | 3.94 (2.58–6.03) |  |
Prior TIA/stroke | ||
 No | 1 | 0.002 |
 Yes | 3.07 (1.50–6.31) |  |